The estimated Net Worth of John Connaughton is at least $3.6 Bilhão dollars as of 29 November 2021. Mr. Connaughton owns over 555,094 units of IQVIA Inc stock worth over $14,805,147 and over the last 21 years he sold IQV stock worth over $3,583,447,961. In addition, he makes $0 as Independent Director at IQVIA Inc.
John has made over 14 trades of the IQVIA Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 555,094 units of IQV stock worth $145,767,684 on 29 November 2021.
The largest trade he's ever made was selling 23,576,519 units of IQVIA Inc stock on 15 February 2013 worth over $845,689,737. On average, John trades about 2,510,804 units every 126 days since 2004. As of 29 November 2021 he still owns at least 62,390 units of IQVIA Inc stock.
You can see the complete history of Mr. Connaughton stock trades at the bottom of the page.
John P. Connaughton serves as Independent Director of the Company. Mr. Connaughton is a Co-Managing Partner and Managing Director of Bain Capital, which he joined in 1989. Prior to joining Bain Capital, Mr. Connaughton was a consultant at Bain & Company, Inc., where he worked in the healthcare, consumer products and business services industries. Mr. Connaughton also serves on the boards of directors of iHeartMedia, Inc. and The Boston Celtics. Mr. Connaughton was formerly a director of Beacon Health Options, Inc., Grupo Notre Dame Intermedica, SunGard Data Systems Inc., Warner Music Group Corp., Warner Chilcott plc, HCA Holdings, Inc., CRC Health Corporation, BIO Products Laboratory, and Air Medical Group Holdings, Inc. He also volunteers for a variety of charitable organizations, serving as a member of The Berklee College of Music Board of Trustees and the University of Virginia McIntire Foundation Board of Trustees. Mr. Connaughton received a Bachelor of Science in Commerce from the University of Virginia and an M.B.A. from Harvard Business School, where he was a Baker Scholar. Because of his extensive experience as a Managing Director of Bain Capital, service on other public company boards and over 15 years’ experience in the private equity industry, as well as extensive experience in the healthcare industry, we believe Mr. Connaughton is well qualified to serve on the Board. For his current term expiring at the 2019 Annual Meeting, Mr. Connaughton was designated for nomination to the Board by Bain Capital pursuant to the Shareholders Agreement described herein. Bain Capital’s designation rights under the Shareholders Agreement ceased in 2018.
John Connaughton is 54, he's been the Independent Director of IQVIA Inc since 2008. There are 15 older and 3 younger executives at IQVIA Inc. The oldest executive at IQVIA Holdings Inc is Ronald Rittenmeyer, 72, who is the Independent Director.
John's mailing address filed with the SEC is C/O IQVIA HOLDINGS INC., 2400 ELLIS ROAD, DURHAM, NC, 27703.
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa..., eGroup Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
IQVIA Inc executives and other stock owners filed with the SEC include: